Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalie M Luiten

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
The Journal of Investigative Dermatology|March 1, 2023
Lower Skin Cancer Risk in Vitiligo: DNA Repair as Potential Mechanism?Rosalie M Luiten
Cancer Treatment and Research|May 6, 2009
Skin immune systemJan D Bos, Rosalie M Luiten
Oncoimmunology|May 6, 2015
Tumor-infiltrating T-cells: important players in clinical outcome of advanced melanoma patientsEsther P M Tjin, Rosalie M Luiten
Current Directions in Autoimmunity|May 8, 2008
Autoimmune etiology of generalized vitiligoI Caroline Le Poole, Rosalie M Luiten
International Journal of Molecular Sciences|July 13, 2024
Regulatory T Cell Dysfunction in Autoimmune DiseasesDionne Y Honing, Rosalie M Luiten, Tiago R Matos
Pigment Cell & Melanoma Research|April 15, 2020
Instant isolation of highly purified human melanocytes from freshly prepared epidermal cell suspensionsMarcella Willemsen, Rosalie M Luiten, Marcel B M Teunissen
Blood|February 15, 2003
Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosisRosalie M Luiten, Jérome Péne, Hans Yssel, et al.
Expert Opinion on Drug Safety|April 26, 2021
Vitiligo induced by immune checkpoint inhibitors in melanoma patients: an expert opinionJanny E Lommerts, Marcel W Bekkenk, Rosalie M Luiten
Pigment Cell & Melanoma Research|June 24, 2019
Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanomaMarcella Willemsen, Rugile Linkutė, Rosalie M Luiten, et al.
Pigment Cell & Melanoma Research|June 22, 2011
Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunityJasper G van den Boorn, Cornelis J Melief, Rosalie M Luiten
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
The Journal of Investigative Dermatology|March 1, 2023
Lower Skin Cancer Risk in Vitiligo: DNA Repair as Potential Mechanism?Rosalie M Luiten
Cancer Treatment and Research|May 6, 2009
Skin immune systemJan D Bos, Rosalie M Luiten
Oncoimmunology|May 6, 2015
Tumor-infiltrating T-cells: important players in clinical outcome of advanced melanoma patientsEsther P M Tjin, Rosalie M Luiten
Current Directions in Autoimmunity|May 8, 2008
Autoimmune etiology of generalized vitiligoI Caroline Le Poole, Rosalie M Luiten
International Journal of Molecular Sciences|July 13, 2024
Regulatory T Cell Dysfunction in Autoimmune DiseasesDionne Y Honing, Rosalie M Luiten, Tiago R Matos
Pigment Cell & Melanoma Research|April 15, 2020
Instant isolation of highly purified human melanocytes from freshly prepared epidermal cell suspensionsMarcella Willemsen, Rosalie M Luiten, Marcel B M Teunissen
Blood|February 15, 2003
Ectopic hTERT expression extends the life span of human CD4+ helper and regulatory T-cell clones and confers resistance to oxidative stress-induced apoptosisRosalie M Luiten, Jérome Péne, Hans Yssel, et al.
Expert Opinion on Drug Safety|April 26, 2021
Vitiligo induced by immune checkpoint inhibitors in melanoma patients: an expert opinionJanny E Lommerts, Marcel W Bekkenk, Rosalie M Luiten
Pigment Cell & Melanoma Research|June 24, 2019
Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanomaMarcella Willemsen, Rugile Linkutė, Rosalie M Luiten, et al.
Pigment Cell & Melanoma Research|June 22, 2011
Monobenzone-induced depigmentation: from enzymatic blockade to autoimmunityJasper G van den Boorn, Cornelis J Melief, Rosalie M Luiten
Pageof 7